Effectiveness of high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with treatment-resistant depression: A randomized clinical trial of 37.5-minute vs 18.75-minute protocol
- PMID: 31240870
- PMCID: PMC7292276
- DOI: 10.1002/npr2.12066
Effectiveness of high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with treatment-resistant depression: A randomized clinical trial of 37.5-minute vs 18.75-minute protocol
Abstract
Aim: Clinical trials and meta-analyses have demonstrated the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the left prefrontal cortex in treatment-resistant depression. The aim of this study was to prospectively evaluate the effectiveness of the conventional 37.5-minute vs 18.75-minute rTMS protocol over the left prefrontal cortex in patients with treatment-resistant depressive episode.
Methods: Thirty patients with treatment-resistant depression or bipolar disorder depressive episode were randomized 1:1 to either 37.5-minute or 18.75-minute rTMS protocol groups. rTMS treatment was applied at 120% resting motor threshold with 10 Hz over the left prefrontal cortex. Treatment sessions were delivered for a total of 3000 pulses/d, 5 days a week, for 4-6 weeks. Patients received a 75 trains with "4 sec on and 26 sec off" for 37.5 minutes or a 75 trains with "4 sec on and 11 sec off" for 18.75 minutes. Severity of depression was rated with the Quick Inventory of Depressive Symptomatology (QIDS) and Patient Health Questionnaire (PHQ-9). Remission was defined as a total score of 5 or less on the QIDS. The primary outcome measure was to compare the remission rate between the both groups.
Results: Thirteen of 30 patients (43.3%) showed remission at week 6. There were no significant differences in the remission rate between the conventional 37.5- and 18.75-minute protocol groups (46.7% and 40.0%, respectively). No seizures or treatment-emergent mania/hypomania were occurred.
Conclusion: These findings suggest that, compared with the conventional one, rTMS with 18.75-minute protocol might be equally effective and clinically beneficial in saving the treatment session length. Further well-designed studies are needed.
Keywords: PHQ-9; Quick Inventory of Depressive Symptomatology; depression; repetitive transcranial magnetic stimulation; stimulation protocol.
© 2019 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of NeuropsychoPharmacology.
Conflict of interest statement
SK reports research grants, speaking fees, or advisory board work with Century Medical, Inter‐Riha, Teijin Pharma, and Vorpal Technologies. The other authors have no financial disclosures or conflicts of interest to report.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7292276/bin/NPR2-39-203-g001.gif)
Similar articles
-
[Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].Encephale. 2014 Feb;40(1):74-80. doi: 10.1016/j.encep.2013.04.004. Epub 2013 Oct 1. Encephale. 2014. PMID: 24091070 French.
-
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.Lancet. 2018 Apr 28;391(10131):1683-1692. doi: 10.1016/S0140-6736(18)30295-2. Epub 2018 Apr 26. Lancet. 2018. PMID: 29726344 Clinical Trial.
-
Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.J ECT. 2017 Sep;33(3):190-197. doi: 10.1097/YCT.0000000000000387. J ECT. 2017. PMID: 28072660 Clinical Trial.
-
[rTMS for treatment resistant depression - proposal for a treatment protocol].Tijdschr Psychiatr. 2018;60(11):766-773. Tijdschr Psychiatr. 2018. PMID: 30484569 Review. Dutch.
-
[Repetitive transcranial magnetic stimulation in major depression: response factor].Encephale. 2012 Sep;38(4):360-8. doi: 10.1016/j.encep.2011.08.004. Epub 2011 Oct 11. Encephale. 2012. PMID: 22980479 Review. French.
Cited by
-
Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions.Neuropsychiatr Dis Treat. 2022 Dec 16;18:2927-2943. doi: 10.2147/NDT.S273503. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36561896 Free PMC article. Review.
-
Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer's dementia in Japan.Front Aging Neurosci. 2022 Oct 13;14:993306. doi: 10.3389/fnagi.2022.993306. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36313021 Free PMC article.
-
Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review.Behav Sci (Basel). 2022 Jun 17;12(6):195. doi: 10.3390/bs12060195. Behav Sci (Basel). 2022. PMID: 35735405 Free PMC article. Review.
References
-
- Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet. 2006;367:153–67. - PubMed
-
- Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–53. - PubMed
-
- Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8. - PubMed
-
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer‐term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17. - PubMed
Publication types
MeSH terms
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical